The desmosomal armadillo protein plakoglobin regulates prostate cancer cell adhesion and motility through vitronectin-dependent Src signaling

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Franzen, Carrie A ^a   Todorović, Viktor ^a   Desai, Bhushan V ^a   Mirzoeva, Salida ^a   Yang, Ximing J ^a   Green, Kathleen J ^a   Pelling, Jill C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLAKOGLOBIN; PROTEIN TYROSINE KINASE; VITRONECTIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

BASE SEQUENCE; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DESMOSOMES; GAMMA CATENIN; HUMANS; MALE; ONCOGENE PROTEIN PP60(V-SRC); PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS; VITRONECTIN;

ARMADILLO;

EID: 84864445109     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042132     Document Type: Article

References (85)

1. Society AC (2010) Cancer Facts & Figures 2010. Atlanta: American Cancer Society.
2. Arya M, Bott SR, Shergill IS, Ahmed HU, Williamson M, et al. (2006) The metastatic cascade in prostate cancer. Surg Oncol 15: 117-128.
3. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
4. Nollet F, Berx G, van Roy F, (1999) The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Commun 2: 77-85.
5. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, et al. (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185.
6. Jarrard DF, Paul R, van Bokhoven A, Nguyen SH, Bova GS, et al. (1997) P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer. Clin Cancer Res 3: 2121-2128.
7. Soler AP, Harner GD, Knudsen KA, McBrearty FX, Grujic E, et al. (1997) Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology. Am J Pathol 151: 471-478.
8. Paul R, Ewing CM, Jarrard DF, Isaacs WB, (1997) The cadherin cell-cell adhesion pathway in prostate cancer progression. Br J Urol 79 Suppl 1: 37-43.
9. Arenas MI, Romo E, Royuela M, Fraile B, Paniagua R, (2000) E-, N- and P-cadherin, and alpha-, beta- and gamma-catenin protein expression in normal, hyperplastic and carcinomatous human prostate. Histochem J 32: 659-667.
10. Breuninger S, Reidenbach S, Sauer CG, Strobel P, Pfitzenmaier J, et al. (2010) Desmosomal plakophilins in the prostate and prostatic adenocarcinomas: implications for diagnosis and tumor progression. Am J Pathol 176: 2509-2519.
11. Whittock NV, Bower C, (2003) Genetic evidence for a novel human desmosomal cadherin, desmoglein 4. J Invest Dermatol 120: 523-530.
12. Clevers H, (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
13. van Hengel J, van Roy F, (2007) Diverse functions of p120ctn in tumors. Biochim Biophys Acta 1773: 78-88.
14. Hatzfeld M, (2006) Plakophilins: Multifunctional proteins or just regulators of desmosomal adhesion? Biochim Biophys Acta 1773: 69-77.
15. Denk C, Hulsken J, Schwarz E, (1997) Reduced gene expression of E-cadherin and associated catenins in human cervical carcinoma cell lines. Cancer Lett 120: 185-193.
16. Giroldi LA, Bringuier PP, Shimazui T, Jansen K, Schalken JA, (1999) Changes in cadherin-catenin complexes in the progression of human bladder carcinoma. Int J Cancer 82: 70-76.
17. Sommers CL, Gelmann EP, Kemler R, Cowin P, Byers SW, (1994) Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res 54: 3544-3552.
18. Shiina H, Breault JE, Basset WW, Enokida H, Urakami S, et al. (2005) Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer. Cancer Res 65: 2130-2138.
19. Todorovic V, Desai BV, Schroeder Patterson MJ, Amargo EV, Dubash AD, et al. (2010) Plakoglobin regulates cell motility through Rho- and fibronectin-dependent Src signaling. J Cell Sci.
20. Yin T, Getsios S, Caldelari R, Kowalczyk AP, Muller EJ, et al. (2005) Plakoglobin suppresses keratinocyte motility through both cell-cell adhesion-dependent and-independent mechanisms. Proc Natl Acad Sci U S A 102: 5420-5425.
21. Cooper CR, Chay CH, Pienta KJ, (2002) The role of alpha(v)beta(3) in prostate cancer progression. Neoplasia 4: 191-194.
22. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, et al. (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818.
23. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, et al. (1994) Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54: 2577-2581.
24. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF, (1978) Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21: 274-281.
25. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW, (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23.
26. Kozlowski JM, Fidler IJ, Campbell D, Xu ZL, Kaighn ME, et al. (1984) Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 44: 3522-3529.
27. Zhau HY, Chang SM, Chen BQ, Wang Y, Zhang H, et al. (1996) Androgen-repressed phenotype in human prostate cancer. Proc Natl Acad Sci U S A 93: 15152-15157.
28. Zhau HE, Odero-Marah V, Lue HW, Nomura T, Wang R, et al. (2008) Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model. Clin Exp Metastasis 25: 601-610.
29. Palka HL, Green KJ, (1997) Roles of plakoglobin end domains in desmosome assembly. J Cell Sci 110 (Pt 19): 2359-2371.
30. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95: 2509-2514.
31. Moss NM, Wu YI, Liu Y, Munshi HG, Stack MS, (2009) Modulation of the membrane type 1 matrix metalloproteinase cytoplasmic tail enhances tumor cell invasion and proliferation in three-dimensional collagen matrices. J Biol Chem 284: 19791-19799.
32. Hudson TY, Fontao L, Godsel LM, Choi HJ, Huen AC, et al. (2004) In vitro methods for investigating desmoplakin-intermediate filament interactions and their role in adhesive strength. Methods Cell Biol 78: 757-786.
33. Getsios S, Simpson CL, Kojima S, Harmon R, Sheu LJ, et al. (2009) Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol 185: 1243-1258.
34. Bass-Zubek AE, Hobbs RP, Amargo EV, Garcia NJ, Hsieh SN, et al. (2008) Plakophilin 2: a critical scaffold for PKC alpha that regulates intercellular junction assembly. J Cell Biol 181: 605-613.
35. Sobin LH, Gospodarowicz MK, Wittekind C (2009) editors (2009) TNM classification of malignant tumours, 7th edition. Oxford: Wiley-Blackwell. 336 p.
36. Pontes-Junior J, Reis ST, Dall'Oglio M, Neves de Oliveira LC, Cury J, et al. (2009) Evaluation of the expression of integrins and cell adhesion molecules through tissue microarray in lymph node metastases of prostate cancer. J Carcinog 8: 3.
37. van Oort IM, Tomita K, van Bokhoven A, Bussemakers MJ, Kiemeney LA, et al. (2007) The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study. Prostate 67: 1432-1438.
38. Kim JB, Islam S, Kim YJ, Prudoff RS, Sass KM, et al. (2000) N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J Cell Biol 151: 1193-1206.
39. Ehrlich JS, Hansen MD, Nelson WJ, (2002) Spatio-temporal regulation of Rac1 localization and lamellipodia dynamics during epithelial cell-cell adhesion. Dev Cell 3: 259-270.
40. Lorch JH, Klessner J, Park JK, Getsios S, Wu YL, et al. (2004) Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. J Biol Chem 279: 37191-37200.
41. Wheelock MJ, Johnson KR, (2003) Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 19: 207-235.
42. Frame MC, (2004) Newest findings on the oldest oncogene; how activated src does it. J Cell Sci 117: 989-998.
43. Fizazi K, (2007) The role of Src in prostate cancer. Ann Oncol 18: 1765-1773.
44. Stewart DA, Cooper CR, Sikes RA, (2004) Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer. Reprod Biol Endocrinol 2: 2.
45. Karlou M, Tzelepi V, Efstathiou E, (2010) Therapeutic targeting of the prostate cancer microenvironment. Nat Rev Urol 7: 494-509.
46. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, et al. (2002) Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 8: 2912-2923.
47. Morrissey C, Vessella RL, (2007) The role of tumor microenvironment in prostate cancer bone metastasis. J Cell Biochem 101: 873-886.
48. Todorovic V, Desai BV, Eigenheer RA, Yin T, Amargo EV, et al. (2010) Detection of differentially expressed basal cell proteins by mass spectrometry. Mol Cell Proteomics 9: 351-361.
49. Playford MP, Schaller MD, (2004) The interplay between Src and integrins in normal and tumor biology. Oncogene 23: 7928-7946.
50. Zheng DQ, Woodard AS, Tallini G, Languino LR, (2000) Substrate specificity of alpha(v)beta(3) integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation. J Biol Chem 275: 24565-24574.
51. Hurt EM, Chan K, Serrat MA, Thomas SB, Veenstra TD, et al. (2010) Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation. Stem Cells 28: 390-398.
52. Cowin P, (1994) Unraveling the cytoplasmic interactions of the cadherin superfamily. Proc Natl Acad Sci 91: 10759-10761.
53. Yin T, Getsios S, Caldelari R, Godsel LM, Kowalczyk AP, et al. (2005) Mechanisms of plakoglobin-dependent adhesion: desmosome-specific functions in assembly and regulation by epidermal growth factor receptor. J Biol Chem 280: 40355-40363.
54. Ruiz P, Brinkmann V, Ledermann B, Behrend M, Grund C, et al. (1996) Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J Cell Biol 135: 215-225.
55. Bierkamp C, McLaughlin KJ, Schwarz H, Huber O, Kemler R, (1996) Embryonic heart and skin defects in mice lacking plakoglobin. Dev Biol 180: 780-785.
56. Green KJ, Simpson CL, (2007) Desmosomes: new perspectives on a classic. J Invest Dermatol 127: 2499-2515.
57. Shimizu M, Fukunaga Y, Ikenouchi J, Nagafuchi A, (2008) Defining the roles of beta-catenin and plakoglobin in LEF/T-cell factor-dependent transcription using beta-catenin/plakoglobin-null F9 cells. Mol Cell Biol 28: 825-835.
58. Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, et al. (2004) Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol 24: 2890-2904.
59. Cowin P, Kapprell HP, Franke WW, Tamkun J, Hynes RO, (1986) Plakoglobin: a protein common to different kinds of intercellular adhering junctions. Cell 46: 1063-1073.
60. Hodivala KJ, Watt FM, (1994) Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation. J Cell Biol 124: 589-600.
61. Levenberg S, Katz B-Z, Yamada KM, Geiger B, (1998) Long-range and selective autoregulation of cell-cell or cell-matrix adhesion by cadherin or integrin ligands. J Cell Sci 111: 347-357.
62. Marsden M, DeSimone DW, (2003) Integrin-ECM interactions regulate cadherin-dependent cell adhesion and are required for convergent extension in Xenopus. Curr Biol 13: 1182-1191.
63. Monier-Gavelle F, Duband J-L, (1997) Cross talk between adhesion molecules: control of N-cadherin activity by intracellular signals elicited by β1 and β3 integrins in migrating neural crest cells. J Cell Biol 137: 1663-1681.
64. Ojakian G, Ratcliffe D, Schwimmer R, (2001) Integrin regulation of cell-cell adhesion during epithelial tubule formation. J Cell Sci 114: 941-952.
65. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
66. Caldelari R, de Bruin A, Baumann D, Suter MM, Bierkamp C, et al. (2001) A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol 153: 823-834.
67. Dusek RL, Godsel LM, Chen F, Strohecker AM, Getsios S, et al. (2007) Plakoglobin deficiency protects keratinocytes from apoptosis. J Invest Dermatol 127: 792-801.
68. Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, et al. (2004) Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Cancer Res 64: 7156-7168.
69. Park SI, Shah AN, Zhang J, Gallick GE, (2007) Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors. Expert Opin Ther Targets 11: 1207-1217.
70. You X, Yu HM, Cohen-Gould L, Cao B, Symons M, et al. (2003) Regulation of migration of primary prostate epithelial cells by secreted factors from prostate stromal cells. Exp Cell Res 288: 246-256.
71. Lee SE, Chung WJ, Kwak HB, Chung CH, Kwack KB, et al. (2001) Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem 276: 49343-49349.
72. Saad F, (2009) Src as a therapeutic target in men with prostate cancer and bone metastases. BJU Int 103: 434-440.
73. Slack JK, Adams RB, Rovin JD, Bissonette EA, Stoker CE, et al. (2001) Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells. Oncogene 20: 1152-1163.
74. Parsons JT, (2003) Focal adhesion kinase: the first ten years. J Cell Sci 116: 1409-1416.
75. Franzen CA, Amargo E, Todorovic V, Desai BV, Huda S, et al. (2009) The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Cancer Prev Res (Phila Pa) 2: 830-841.
76. Yin T, Green KJ, (2004) Regulation of desmosome assembly and adhesion. Semin Cell Dev Biol 15: 665-677.
77. McCrea PD, Gu D, Balda MS, (2009) Junctional Music that the Nucleus Hears: Cell-Cell Contact Signaling and the Modulation of Gene Activity. Cold Spring Harb Perspect Biol 1: a002923.
78. Lombardi R, da Graca Cabreira-Hansen M, Bell A, Fromm RR, Willerson JT, et al. (2011) Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res 109: 1342-1353.
79. Seiffert D, Curriden SA, Jenne D, Binder BR, Loskutoff DJ, (1996) Differential regulation of vitronectin in mice and humans in vitro. J Biol Chem 271: 5474-5480.
80. Chidgey M, Dawson C, (2007) Desmosomes: a role in cancer? Br J Cancer 96: 1783-1787.
81. Jeanes A, Gottardi CJ, Yap AS, (2008) Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27: 6920-6929.
82. Takeichi M, (1993) Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 5: 806-811.
83. Aberle H, Bierkamp C, Torchard D, Serova O, Wagner T, et al. (1995) The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. Proc Natl Acad Sci U S A 92: 6384-6388.
84. Winn RA, Bremnes RM, Bemis L, Franklin WA, Miller YE, et al. (2002) gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene 21: 7497-7506.
85. Rieger-Christ KM, Ng L, Hanley RS, Durrani O, Ma H, et al. (2005) Restoration of plakoglobin expression in bladder carcinoma cell lines suppresses cell migration and tumorigenic potential. Br J Cancer 92: 2153-2159.